Healthcare cybersecurity company MedCrypt has acquired cybersecurity information-sharing organisation MedISAO for an undisclosed amount.

The acquisition enables MedCrypt to offer MedISAO’s solutions alongside its flagship software products.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

These include MedISAO’s information-sharing analysis network for small and midsize business (SMB), the Cyber Protek Software Bill of Materials (SBoM) and dependency vulnerability management tool.

As part of the deal, MedISAO founder Daniel Beard will join the MedCrypt team.

MedCrypt CEO Mike Kijewski said: “It can take anywhere from six months to a year for a new medical device to get its 510(k) clearance from the FDA.

“Our goal is to help device manufacturers meet the requirements from the FDA’s premarket and postmarket cybersecurity guidance, and MedISAO’s information-sharing organisation and Software Bill of Materials tool help us do just that. Together, we are helping manufacturers bring critical medical devices to market more quickly, reliably and safely.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The Food and Drug Administration (FDA) encourages medical device manufacturers to participate in a vulnerability sharing under its postmarket cybersecurity guidance. MedISAO is one of the three information-sharing and analysis organisations that were formed to meet this recommendation from the regulatory agency.

MedISAO members are provided with weekly vulnerability advisories, coordinated vulnerability disclosure forms and access to a vulnerability database with custom filters.

The Cyber Protek solution offers clients access to an SBoM generation tool and enables them to evaluate vulnerabilities that affect their device and use its medical device management platform.

Daniel Beard said: “I initially created MedISAO to help fill the information-sharing gap among smaller medical device manufacturers that were just getting started with cybersecurity. As demand for our platform grew, we realised our customers were in need of a Software Bill of Materials tool as well, so we created Cyber Protek.

“Joining MedCrypt will help both companies’ customers to expedite, manage and demonstrate cybersecurity compliance, increasing security and decreasing the time it takes for life-saving devices to market.”

Following the acquisition, MedCrypt and MedISAO will work together to enhance medical device cybersecurity across the healthcare space. The merged entity will also continue to collaborate with industry partners, including Health Information Sharing & Analysis Center (H-ISAC).

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact